Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-004041
Filing Date
2020-02-10
Accepted
2020-02-10 16:06:50
Documents
67
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 ENTA_Q1_FY20 enta-10q_20191231.htm   iXBRL 10-Q 2147208
2 EX-31.1 enta-ex311_6.htm EX-31.1 16201
3 EX-31.2 enta-ex312_8.htm EX-31.2 16187
4 EX-32.1 enta-ex321_7.htm EX-32.1 8933
5 GRAPHIC gfggzg3o01kk000001.jpg GRAPHIC 62950
  Complete submission text file 0001564590-20-004041.txt   7983567

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20191231.xsd EX-101.SCH 39766
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20191231_cal.xml EX-101.CAL 61236
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20191231_def.xml EX-101.DEF 108904
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20191231_lab.xml EX-101.LAB 350432
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20191231_pre.xml EX-101.PRE 280854
68 EXTRACTED XBRL INSTANCE DOCUMENT enta-10q_20191231_htm.xml XML 1700433
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 20591931
SIC: 2834 Pharmaceutical Preparations